J-Oil Mills developed menatto vitamin K2 (MK-7), made from a bacterial strain isolated from the traditional fermented Japanese food natto using a natural fermentation process.
J-Oil Mills (Tokyo, Japan) developed menatto vitamin K2 (menaquinone-7 or MK-7), made from a bacterial strain isolated from the traditional fermented Japanese food natto using a natural fermentation process. The ingredient supports bone health, heart health, joint health, hair/skin/nails, and healthy blood coagulation.
“Developed through a natural fermentation process, menatto is the genuine Japanese vitamin K2 (MK-7),” said Hikaru Asari, senior executive, fine materials department and food and fine materials business unit for J-Oil Mills, in a press release. “This is why we created the menatto tagline, The Japanese Original.
“Menatto is backed by 10 well-controlled human clinical trials, all published in peer-reviewed scientific journals,” Asari continued. “The ingredient is supported by original clinical research and a suite of intellectual property, including three international product usage patents and a Japanese process patent and trademarks.”
Menatto is manufactured in a GMP and ISO 22000-certified facility in Japan and has achieved self-affirmed GRAS and novel food status, allowing for its use in foods and beverages, as well as conventional tablets, capsules, gummies, and chews.
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.